Download The AC Seattle Tourist Guide

[vc_row][vc_column width=”2/3″][vc_column_text] Download The AC Seattle Tourist Guide Seattle is a one of the United States’ most diverse cities, attracting a wide range of residents and visitors from across the world. Its most recognizable landmark and...

Taking Clinicaltrials.gov to the next level

At a recent partner event, I had the pleasure of speaking with Sally Okun, VP Advocacy, Policy and Patient Safety at PatientsLikeMe®. She shared her thoughts on the increasing role of patients in clinical trials.  Her comments were similar to those expressed at a...

Addressing the Opioid Overdose Crisis – A DIA 2018 Takeaway

We’re back from DIA 2018 and enjoyed a few key topics that are getting attention now as we approach a new era in healthcare. Here’s our takeaway on the keynote “Opioid Epidemic.” Nora Volkow M.D., Director of the National Institute on Drug Abuse (NIDA) at the National...

Thoughts on AI in Clinical Trials

The recent 2018 Clinical Trial Innovation Summit had a session titled: “What Are the Opportunities and Challenges with Applying Machine Learning and AI to Clinical Trials?” A panel of experts from Bayer, Roche and Janssen discussed how AI and Machine Learning can be...

Clinical Trial Innovation Summit 2018: Our Take

We’re back from the 2018 Clinical Trial Innovation Summit that took place in Boston where a great deal of focus was on the concept of siteless clinical trials or virtual clinical trials. The definition varied from breakout to breakout as everyone admitted that this...

Who Is Determining the Efficacy of mHealth and Wearables?

  Back in 2017, many of us in the Pharma Informatics industry wrote opinions about wearables in clinical trials.  In fact, it was the year we were all fixated on it. This new technology was partly driven by the mega trend of leveraging tablets and smartphones in...